Breaking
🌏 NMPA
Australia's TGA Updates In Vitro Diagnostic Device Regulations for Medical Device Manufacturers
NewsApr 22, 2026

Australia's TGA Updates In Vitro Diagnostic Device Regulations for Medical Device Manufacturers

Australia's Therapeutic Goods Administration releases comprehensive guidance for in vitro diagnostic device manufacturing, applications, and market authorization.

Dr. Yuna Park
PMDA Approves Peripheral Rotablator PRO and Visual-ICE Cryoablation System Modifications in Japan
NewsApr 21, 2026

PMDA Approves Peripheral Rotablator PRO and Visual-ICE Cryoablation System Modifications in Japan

Japan's PMDA grants partial change approval for Peripheral Rotablator PRO and Visual-ICE Cryoablation System, expanding cardiovascular treatment options.

Dr. Yuki Tanaka
Australia's TGA Expands Therapeutic Vaping Access Through Pharmacy Channels with New Regulatory Framework
NewsApr 18, 2026

Australia's TGA Expands Therapeutic Vaping Access Through Pharmacy Channels with New Regulatory Framework

Australia's TGA establishes new pathways for therapeutic vaping products through pharmacies, expanding access to regulated e-cigarettes as therapeutic goods.

Dr. Yuki Tanaka
TGA Updates Medical Device Regulations for AI and Software-Based Therapeutic Products in Australia
NewsApr 18, 2026

TGA Updates Medical Device Regulations for AI and Software-Based Therapeutic Products in Australia

Australia's TGA provides comprehensive regulatory guidance for medical devices including AI and software products through ARTG registration and manufacturing standards.

Dr. Priya Sharma
Phantom Neuro Receives Approval for First Human Trial of Phantom X Neural Interface System
NewsApr 16, 2026

Phantom Neuro Receives Approval for First Human Trial of Phantom X Neural Interface System

Phantom Neuro gets approval for first-in-human trial of Phantom X neural interface system in Australia, marking major milestone for prosthetic control technology.

Dr. Yuki Tanaka
WuXi Biologics Achieves ISO 13485 Certification for Drug-Device Combination Products Manufacturing
NewsApr 15, 2026

WuXi Biologics Achieves ISO 13485 Certification for Drug-Device Combination Products Manufacturing

WuXi Biologics becomes first in China to achieve ISO 13485:2016 certification with zero non-conformities for drug-device combination product development.

Dr. Priya Sharma